R egulation of cellular events is a complex process that involves sev eral factors in their specific interactions and interplays. However, within this complexity exist also signs of specificity and changes in single protein could sig nificantly influence the properties and responses of cells.
Recently, Ramirez and colleagues [1] provided innovative results that empha size the important and selective role of one specific protein, α 2 integrin, in the complex process of tumor metastasis. This protein, as a part of heterodimeric α2β1 integrin, was identified as a meta stasis suppressor in both breast and prostate cancer. Tumor metastasis is a process by which tumor cells spread from original source tissue to distant sites within the body, and it is not a single event but requires a series of steps. The known key cellular events required for meta stasis include invasion of the surround ing stromal tissue, intravasation, eva sion of programmed cell death, arrest within the vasculature at a distant site, extravasation, and establishment and growth within a new microenviron ment [2] . However, despite intensive research focused on the process of tumor progression and metastasis, the molecu lar factors involved and mechanisms that determine and drive the dynamic process of cancer metastasis are not fully elucidated. For a better understanding of the biological processes that underline metastasis is essential to identify indi vidual systems that play a key role in these processes.
The study of Ramirez and colleagues [1] represents a valuable contribution to the identification of specific factors that play the key role in tumor invasion. Their data provide important information for identification of potential molecu lar mechanisms involved in metastatic responses. They highlight the power of a single protein, α 2 integrin, in modula tion of tumor invasion and identify also the key mechanistic steps involved in stimulation of metastatic cascade in con sequence of loss of α2β1 integrin expre ssion. The principal model used for the study of processes of breast cancer initia tion and progression was a clinically rel evant model of tumorprone genetically engineered animals that spontaneously develop metastasis [mouse mammary tumor virusNeu (MMTVNeu) model]. The selective role of α 2 integrin, as a part of heterodimer α2β1, in breast cancer progression was explored using animals with deleted gene for this protein.
Other experimental approaches validated the observed role of the α 2 integrin as a metastasis suppressor also in subtypes of human cancer. Massive metastatic progression of breast cancer is direct causality of patient death. Therefore, the research focused on regulatory points of meta static cascade is of great importance. In this respect, recent findings suggest direct links among integrins and tumor metastasis [3] . The integrins are family of extracellular matrix receptors and their actions could be related to altered acti vation of matrix metalloproteinases [4] . Functions of matrix metalloproteinases were described to be related to intracel lular signaling pathways that include some kinase cascades such as ERK [4] and Rho [5] . Detailed description of regula tory sequence determining specific role of α 2 integrin, metalloproteinases and protein kinases in formation of metasta sis needs to be studied in future.
Results of Ramirez and colleagues' study further expand our knowledge about the importance of α 2 integrin in cancer progression, and could be explored in improvement of specific diagnosis of breast cancer metastatic potential. Finally, α 2 integrin has to be considered as a potential therapeutic tar get in the treatment of this disease. 
